ERBB2 and ovarian adenocarcinoma: For example, D’Huyvetter et al. treated mice bearing HER2-positive SKOV3 ovarian adenocarcinoma xenografts with the 177Lu-labeled anti-HER2 VHH and demonstrated that the tumor growth was almost completely inhibited.